J&J Medical Device And Diagnostics Thrives On Strength Of Cordis In Q4
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson highlighted its Cordis cardiovascular franchise as a key contributor to a 9.1% increase in its Medical Device and Diagnostics segment sales to $2.87 bil. in the fourth quarter